-
Post date
August 8, 2022
-
Posted by
Vishal Toora
-
Posted in
2022 canadian psychedelics stocks, anxiety, Canadian psychedelics, investments, Mind Medicine, MindMEd, Mushrooms, Numi Wellness, Psychedelic Stocks, Psychedelics, Psychedelics ETF, shroom-stocks, stock market, stocks, uptrend
-
Post date
June 29, 2022
-
Posted by
Kieran Robertson
-
Posted in
Ecstasy, Health Canada approval, Health Canada restricted drug amendments, Mushrooms, OPTI.C, Optimi, Optimi Health, Optimi Health Corp., psilocybin, psychedelic assisted therapy, psychedelic drug market, Psychedelics, SABI Mind, SAP, Special Access Program
-
Post date
June 29, 2022
-
Posted by
Kieran Robertson
-
Posted in
Ecstasy, Health Canada approval, Health Canada restricted drug amendments, Mushrooms, OPTI.C, Optimi, Optimi Health, Optimi Health Corp., psilocybin, psychedelic assisted therapy, psychedelic drug market, Psychedelics, SABI Mind, SAP, Special Access Program